Onepod 200 DT Tablet contains Cefpodoxime Proxetil 200 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefpodoxime Proxetil is a prodrug that, upon absorption, is converted to the active form, cefpodoxime, which inhibits bacterial cell wall synthesis, leading to cell lysis and death. This antibiotic is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Onepod 200 DT Tablet is formulated as a dispersible tablet, facilitating ease of administration, particularly in pediatric and geriatric patients who may have difficulty swallowing conventional tablets. The drug demonstrates good oral bioavailability and achieves effective tissue penetration. It is generally well tolerated; however, hypersensitivity reactions, gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort may occur. Use of this medication should be guided by susceptibility testing and clinical judgment to minimize the development of resistance. It is contraindicated in patients with known hypersensitivity to cephalosporins or penicillins. Dosage adjustments may be necessary in patients with renal impairment. Onepod 200 DT Tablet should be used under medical supervision to ensure optimal therapeutic outcomes.